AVIR Operating Cash Flow Growth
Atea Pharmaceuticals Inc · Operating Cash Flow Growth
AVIR Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-30.13%period ending
AVIR TTM Cash from Operations YoY % (2415.70% → -30.13%)
Year-over-year change
High-resolution chart · PNG
AVIR operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -30.1271% | |
| -17.1652% | |
| 2.5594% | |
| -5.7265% | |
| 3.8085% | |
| -32.2681% | |
| -58.6732% | |
| -49.1505% | |
| -36.8816% | |
| -3.9064% | |
| 29.4151% | |
| 51.3291% | |
| 32.2543% | |
| 28.9169% | |
| -39.0518% | |
| -156.969% | |
| -147.667% | |
| -145.4201% | |
| -129.3209% | |
| 1,293.6185% | |
| 1,480.2792% | |
| 2,130.4491% | |
| 2,415.7016% |